Goldman Sachs’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Goldman Sachs’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,123,647	Closed	-$19M	–	6072
2023 Q2	$19M	Buy	1,123,647 +1,096,570	+4,050%	+$14.4M	﹤0.01%	1899
2023 Q1	$230K	Buy	+27,077	New	+$223K	﹤0.01%	5235

Other funds holding VECT

Regency Capital Management Honolulu, Hawaii $251M AUM 32.13% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Goldman Sachs's VECT Position: Q3 2023 in Review

Goldman Sachs sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 1,123,647 shares — an estimated $19M sold.

Goldman Sachs first reported a position in VECT in Q1 2023 and held it in 2 quarters. The position peaked at $19M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Goldman Sachs reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Goldman Sachs sold 1,123,647 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $19M.
Goldman Sachs first reported a position in VectivBio Holding AG Ordinary Shares in Q1 2023 and held it in 2 quarters.
Goldman Sachs's VectivBio Holding AG Ordinary Shares position peaked at $19M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.